Skip to main content
Clinical Trials/NCT03466684
NCT03466684
Completed
Not Applicable

Bioelectrical Impedance Analysis Guided-Fluid Management Promotes Primary Fascial Closure of Postinjury Open Abdomen

Nanjing PLA General Hospital0 sites140 target enrollmentJanuary 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Damage Control
Sponsor
Nanjing PLA General Hospital
Enrollment
140
Primary Endpoint
Rate of 30-day primary fascial closure
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Fluid overload (FO), resulting from high volume fluid therapy, is frequent and contributes to excessive visceral edema, delayed fascial closure, and adverse outcomes among postinjury open abdomen (OA) patients. Bioelectrical impedance analysis (BIA) is a promising tool in monitoring fluid status and FO. Thus, we sought to investigate the efficacy of BIA-directed resuscitation among postinjury OA patients.

Registry
clinicaltrials.gov
Start Date
January 1, 2013
End Date
March 31, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nanjing PLA General Hospital
Responsible Party
Principal Investigator
Principal Investigator

Gao Tao

Clinical Professor

Nanjing PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult trauma patients admitted to SICU with OA after emergent abbreviated laparotomy were considered eligible.

Exclusion Criteria

  • (a) age less than 18 years; (b) pregnancy; (c) lactation; (d) limb amputations; (e) mental disorders; (f) diabetes mellitus; (g) pre-existing blood disorders; (h) pre-existing abdominal fistulas; (i) pre-existing terminal illness; (j) liver dysfunction (Child-Pugh class C); (k) New York Heart Association (NYHA) class IV; (l) chronic renal failure requiring dialysis; (m) therapy with an extra-corporeal membrane oxygenator (ECMO); (n) enrolled in an ongoing, interventional RCT; (o) received prior fluids for resuscitation during their ICU stay; (p) expected to die within 1 hour of ICU admission for devastating injuries; (q) activated opt-out process for BGFM trial.

Outcomes

Primary Outcomes

Rate of 30-day primary fascial closure

Time Frame: 30 days

Rate of 100% direct approximation of abdominal fascial edges

Secondary Outcomes

  • Time to fascial closure(30 days)
  • Postoperative 7-day fluid volume(7 days)
  • Postoperative 30-day mortality(30 days)
  • Postoperative 30-day adverse effects(30 days)

Similar Trials